UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement | |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
| ☐ | Definitive Proxy Statement | |
| ☒ | Definitive Additional Materials | |
| ☐ | Soliciting Material under § 240.14a-12 | |
Inari Medical, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. | |||
| ☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
| (1) | Title of each class of securities to which transaction applies:
| |||
| (2) | Aggregate number of securities to which transaction applies:
| |||
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
| |||
| (4) | Proposed maximum aggregate value of transaction:
| |||
| (5) | Total fee paid:
| |||
| ☐ | Fee previously paid with preliminary materials. | |||
| ☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | |||
| (1) | Amount Previously Paid:
| |||
| (2) | Form, Schedule or Registration Statement No.:
| |||
| (3) | Filing Party:
| |||
| (4) | Date Filed:
| |||
Inari Medical, Inc. Important Notice Regarding the Availability of Proxy Materials
P.O. BOX 8016, CARY, NC 27512-9903
Stockholders Meeting to be held on
May 27, 2021
For Stockholders as of record on March 31, 2021
This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to
vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.
To view the proxy
materials, and to obtain directions to attend meeting, go to: www.proxydocs.com/NARI
To vote your proxy while visiting this site, you will need the 12 digit
control number in the box below.
Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy
materials can be distributed by making them available on the internet.
CONTROL NUMBER
For a convenient way to view proxy materials and VOTE go to www.proxydocs.com/NARI
Have the 12
digit control number located in the shaded box above available when you access the website and follow the instructions.
If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year’s meeting, you must make this request on or
before May 17, 2021.
To order paper materials, use one of the following methods.
INTERNET www.investorelections.com/NARI
TELEPHONE (866)
648-8133
* E-MAIL paper@investorelections.com
When requesting via the Internet or telephone you will need the 12 digit * If requesting material by e-mail, please send a blank
e-mail with the 12 digit control number (located above) control number located in the shaded box above. in the subject line. No other requests, instructions OR other inquiries
should be included with your e-mail requesting material.
Inari Medical, Inc.
Meeting Type: Annual Meeting of Stockholders Date: Thursday, May 27, 2021 Time: 08:00 AM, Pacific Time
Place: Annual Meeting to be held live via the Internet—please visit www.proxydocs.com/NARI for more details.
You must pre-register at www.proxydocs.com/NARI by May 26, 2021 5:00 PM ET to attend the meeting online.
SEE REVERSE FOR FULL AGENDA
Inari Medical, Inc.
Annual Meeting of Stockholders
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSALS 1 AND 2.
PROPOSAL
| 1. | To elect the three nominees for Class I director to serve until the 2024 annual meeting of stockholders and until their successors are duly elected and qualified. |
1.01 William Hoffman
1.02 Donald Milder
1.03 Geoff Pardo
| 2. | To ratify the selection of BDO USA, LLP as the independent registered public accounting firm for Inari Medical, Inc. for the fiscal year ending December 31, 2021. |
| 3. | To conduct any other business properly brought before the Annual Meeting. |